Cytek Biosciences, Inc. Common Stock (NASDAQ: CTKB) last traded at $4.81, up 3.22% on the session. The quote above updates while this page is open; the figures below are drawn from Cytek Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cytek Biosciences, Inc. Common Stock trades on NASDAQ under the ticker CTKB. Its market capitalisation is $625.22 million.
Valuation measures for Cytek Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $625.22M |
|---|---|
| Enterprise value | $676.35M |
| Price / sales | 3.02 |
| Price / book | 1.94 |
| Beta | 0.98 |
Trailing-twelve-month figures tagged in Cytek Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $206.71M |
|---|---|
| Net income (TTM) | -$80.58M |
| Gross margin | 53.23% |
| Operating margin | -21.60% |
| Return on equity | -25.03% |
| Cash | $73.85M |
Range and volume for CTKB over the past 52 weeks.
| 52-week high | $6.18 |
|---|---|
| 52-week low | $3.28 |
| Volume | 790.5K |
| Average volume | 1.33M |
| Previous close | $4.66 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.